Parasitic Diseases
9
1
1
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (9)
Diagnosis and Treatment of Leishmania Infections
Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum
Malaria Elimination Pilot Study in Military Forces in Cambodia
Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158
Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya
Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis Elimination
Safety and Efficacy of Drug Combinations Against Schistosomiasis
Safety and Efficacy of Drug Combinations Against Trichuris Trichiura
Safety and Efficacy of Drug Combinations Against Triple Infections